Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_assertion description "[Here we find that nucleolin (NCL), a major nucleolar protein, posttranscriptionally regulates the expression of a specific subset of miRNAs, including miR-21, miR-221, miR-222, and miR-103, that are causally involved in breast cancer initiation, progression, and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_assertion evidence source_evidence_literature NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_assertion SIO_000772 23610125 NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_assertion wasDerivedFrom befree-20140225 NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_assertion wasGeneratedBy ECO_0000203 NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP178224.RAOd5nNCp6eTB4AormX1yVRM26VG4Cq-fi3fmNkS2SjfQ130_provenance.